Law & Policy

·

News

Wisconsin Researchers Lead U.S. Psilocybin Clinical Trials

Wisconsin Researchers Lead U.S. Psilocybin Clinical Trials

Psilocybin mushrooms

What they found

UW–Madison and the Usona Institute are testing psilocybin for depression, PTSD and addiction under FDA breakthrough status.

UW–Madison and the Usona Institute are testing psilocybin for depression, PTSD and addiction under FDA breakthrough status.

How solid is it?

n/a

n/a

Not a study

Not a study

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Compound

psilocybin

psilocybin

Published in

WPR

WPR

Covered in Shroom Scan

Section

PSILOCYBIN & LEGISLATION

PSILOCYBIN & LEGISLATION

As it ran in Shroom Scan

Wisconsin Leads Psilocybin Trials

Wisconsin Leads Psilocybin Trials

Researchers at UW–Madison and the Usona Institute are at the forefront of testing psilocybin for depression, PTSD, and addiction. Trials show lasting symptom relief for some patients, with Usona manufacturing the psilocybin used in studies nationwide under FDA “breakthrough therapy” status. While regulators recently rejected MDMA-assisted therapy, scientists believe psilocybin could be next in line for federal approval, potentially making Wisconsin a hub for psychedelic medicine.

Researchers at UW–Madison and the Usona Institute are at the forefront of testing psilocybin for depression, PTSD, and addiction. Trials show lasting symptom relief for some patients, with Usona manufacturing the psilocybin used in studies nationwide under FDA “breakthrough therapy” status. While regulators recently rejected MDMA-assisted therapy, scientists believe psilocybin could be next in line for federal approval, potentially making Wisconsin a hub for psychedelic medicine.

Veterans Heal, Rivers Recover, and Mushroom Blends May Be Better

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.